MyFinsight
Home
Blog
About
North American
Pharmaceutical Segment
$86,773M
Oncology And
Multispecialty Segment
$14,222M
Medical Surgical
Solutions Segment
$2,819M
(4.37%↑ Y/Y)
Prescription Technology
Solutions Segment
$1,566M
(9.21%↑ Y/Y)
Revenues
$105,380M
(7.72%↑ Y/Y)
Gross profit
$3,685M
(12.38%↑ Y/Y)
Cost of sales
$101,695M
(7.56%↑ Y/Y)
Operating income
$1,319M
(27.32%↑ Y/Y)
Other income, net
$66M
(3.13%↑ Y/Y)
Total operating
expenses
$2,366M
(5.48%↑ Y/Y)
Claims and litigation
charges, net
$34M
Income before income
taxes
$1,308M
(24.45%↑ Y/Y)
Interest expense
$77M
(57.14%↑ Y/Y)
Selling, distribution,
general, and...
$2,264M
(3.10%↑ Y/Y)
Restructuring, impairment, and
related charges, net
$136M
(189.36%↑ Y/Y)
Net income
$1,032M
(24.19%↑ Y/Y)
Income tax expense
$276M
(25.45%↑ Y/Y)
Net income
attributable to mckesson...
$614M
(-21.68%↓ Y/Y)
Net income
attributable to...
$418M
(789.36%↑ Y/Y)
Back
Back
Income Statement
mck_logo_blue-svg
MCKESSON CORP (MCK)
mck_logo_blue-svg
MCKESSON CORP (MCK)
source: myfinsight.com